Document is current
Any future updates will be listed below
-
Authors
Terasaki, Dale https://orcid.org/0000-0001-8164-1608
Loh, Ryan
Cornell, Anastasia
Taub, Julie
Thurstone, Christian
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04562779 at ClinicalTrials.govDocuments that mention this clinical trial
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates
https://doi.org/10.1186/s13722-022-00345-y
-
Funding
Funding for this research was provided by:
Denver Health & Hospital Authority
- License Information
-
More Information
Article History
Received: 12 June 2022
Accepted: 24 October 2022
First Online: 22 November 2022
Declarations
:
: This study and the informed consent process was approved by the Colorado Multiple Institutional Review Board (IRB# 20-2008). All participants provided written and verbal consent, facilitated at bedside by the principal investigator.
: The consent process included mention of publication.
: The authors declare that they have no competing interests.
